Nexstim H1 2021: Our initial take
We give our take on today’s H1 report from Nexstim. We are overall pleased with the developments in Nexstim so far this year, as sales exceeded our estimates with significant growth across the board. At this point, we make some adjustments to our full year estimates and increase our base case to SEK 60 (55).
Sign up for free to continue
Already a member?
Disclosures and disclaimers
Premium Plan required to unlock